Statins are among the most widely prescribed drugs in the western world, used to treat elevated cholesterol levels and reduce the risk of cardiovascular disease. While statins are highly effective and generally safe, adverse effects occur in a small proportion of users, which represents a large number of individuals due to statins' widespread use. In some individuals, statins adversely affect muscle, with symptoms ranging from mild pain to rhabdomyolysis. Recent studies have also shown a 9-12% increase in risk for type 2 diabetes among statin users. We hypothesize that many of the genetic variants and molecular mechanisms that influence statin-related myopathy and new-onset diabetes remain to be identified. In preliminary work, we have established that the mouse is a feasible model in which to identify genetic variation in statin-related muscle toxicity and dysglycemia, and it offers superior features for genetic and molecular analysis. In this Project, we will utilize a novel mouse genetics resource, the Hybrid Mouse Diversity Panel (HMDP), which consists of ~110 inbred mouse stains. We will use the HMDP to identify genes (Aim 1) and mechanisms (Aim 2) underlying statin-associated myotoxicity and diabetes.
In Aim 3 we will perform in vivo studies in the mouse to validate selected genes identified in human studies in other projects within this Center. Innovative features of our approach include the ability to perform genetic association to high resolution in the HMDP, often to loci containing just a handful of genes. Additionally, our studies will include full HMDP sets of males and females, providing the opportunity to identify sex-specific statin effects. Our preliminary studies have identified effects of statins on protein kinase D signaling and autophagy in myocytes and beta cells, and we will elucidate these further at the physiological, cellular and molecular levels. These studies, together with the translation of human genetic variants to in vivo mouse models, will inform us about potential genetic and molecular markers that may be valuable for the evaluation of individual benefit versus risk of statin drug treatment.

Public Health Relevance

PROJECT 2: NARRATIVE Statins are among the most widely prescribed drugs in the western world, and are highly effective in reducing the risk of cardiovascular disease. However, adverse effects include myopathy and increased risk for type 2 diabetes. Here we will use a unique mouse genetic resource to identify gene variants associated with statin adverse effects in males and females. We will also characterize the underlying molecular mechanisms to promote the identification of biomarkers. The genetic variants and biomarkers identified will be validated and tested for their role in humans in other projects of this Center. Hence, findings from this project may be valuable for evaluation of individual benefit versus risk of statin drug treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
5P50GM115318-03
Application #
9326332
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2017-09-01
Budget End
2018-08-31
Support Year
3
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Children's Hospital & Res Ctr at Oakland
Department
Type
DUNS #
076536184
City
Oakland
State
CA
Country
United States
Zip Code
94609
Lee, Seung-Been; Wheeler, Marsha M; Patterson, Karynne et al. (2018) Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model. Genet Med :
Kim, Dongwook; Shivakumar, Manu; Han, Seonggyun et al. (2018) Population-dependent Intron Retention and DNA Methylation in Breast Cancer. Mol Cancer Res 16:461-469
Miller, Jason E; Shivakumar, Manu K; Risacher, Shannon L et al. (2018) Codon bias among synonymous rare variants is associated with Alzheimer's disease imaging biomarker. Pac Symp Biocomput 23:365-376
Oni-Orisan, Akinyemi; Hoffmann, Thomas J; Ranatunga, Dilrini et al. (2018) Characterization of Statin Low-Density Lipoprotein Cholesterol Dose-Response Using Electronic Health Records in a Large Population-Based Cohort. Circ Genom Precis Med 11:e002043
Orozco, Luz D; Farrell, Colin; Hale, Christopher et al. (2018) Epigenome-wide association in adipose tissue from the METSIM cohort. Hum Mol Genet 27:1830-1846
Kim, Kyungpil; Theusch, Elizabeth; Kuang, Yu-Lin et al. (2018) ZNF542P is a pseudogene associated with LDL response to simvastatin treatment. Sci Rep 8:12443
Veturi, Yogasudha; Ritchie, Marylyn D (2018) How powerful are summary-based methods for identifying expression-trait associations under different genetic architectures? Pac Symp Biocomput 23:228-239
Lee, Younghee; Han, Seonggyun; Kim, Dongwook et al. (2018) Genetic variation affecting exon skipping contributes to brain structural atrophy in Alzheimer's disease. AMIA Jt Summits Transl Sci Proc 2017:124-131
Hoffmann, Thomas J; Theusch, Elizabeth; Haldar, Tanushree et al. (2018) A large electronic-health-record-based genome-wide study of serum lipids. Nat Genet 50:401-413
El-Manzalawy, Yasser; Hsieh, Tsung-Yu; Shivakumar, Manu et al. (2018) Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data. BMC Med Genomics 11:71

Showing the most recent 10 out of 21 publications